Should You Trim Or Add To Your Hims & Hers Position Now?
Hims & Hers Health (HIMS) stock fell 52% in 12 months, despite 40% sales growth in Q2 2026. Growth drivers include expanded weight loss products, Eucalyptus acquisition, and international revenue. Gross margin fell to 64%, and the company reported a net loss of $86 million. The FTC filed a complaint, and the company faces a securities class action.
How this was made

The 30-second read
Why it matters
The recap highlights ongoing margin compression and legal risk, suggesting limited near‑term upside.
Market read
The article offers a post‑earnings perspective on HIMS, reinforcing a bearish outlook due to margin and regulatory concerns.
What to watch
International revenue grew 17‑fold, indicating strong overseas demand that could offset U.S. margin compression.
Background
The piece summarizes Hims & Hers Health's recent quarterly performance and regulatory exposure, providing context for investors evaluating the stock after a steep decline.
Ticker impact
The article recaps Hims & Hers Health's Q2 2026 results, noting a 52% share decline, 40% sales growth, a $40 M acquisition of Eucalyptus, and an ongoing FTC complaint.
likely downward pressure as investors price in lower margins and legal uncertainty
The company posted a net loss of $86 M, margin fell 6 points, and the FTC lawsuit adds a regulatory headwind; no new positive catalyst was disclosed.
Market effects
Telehealth and consumer health firms may see heightened scrutiny as FTC actions increase regulatory risk.
U.S. investors may reduce exposure to Hims & Hers and similar health‑tech stocks.
Limited; the story is company‑specific with no broader macro impact.
Counterpoint
If the weight‑loss product line scales efficiently, margin could recover, offering upside despite short‑term pressure.
Key entities
- CompanyHims & Hers Health
U.S. telehealth and consumer health company (ticker HIMS).
- Acquired CompanyEucalyptus
Provider acquired by Hims & Hers, contributing $40 M revenue.
- RegulatorFederal Trade Commission
Filed a complaint against Hims & Hers in July 2024.
